About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01626235

AMPED Outcomes Registry of Post-ED Pain Management

Study aims to assess patient-recorded outcomes of pain control medications prescribed in the ER after visits for specific painful injuries/illnesses.

Lead sponsor: Radnor Registry Research, Inc•11 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Radnor Registry Research, Inc

Collaborators

American Regent, Inc.

Multicenter, observational, prospective, out-of-hospital registry collecting clinical, satisfaction, quality of life, and healthcare resource utilization from subjects discharged after ED care for a specific acute pain syndrome with a clinician-determined analgesic regimen. Subjects are stratified by diagnosis and by regimen based on the treating clinician's judgment. The registry study is independent of ED care and clinician's decision-making.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Eligible subjects will meet the following criteria:
•1. Eligible diagnoses:
•musculoskeletal etiologies: acute extremity fractures sprains/strains acute gouty arthritis visceral etiologies: renal colic dysmenorrhea
•2. Age GTE 18 years;
•3. Decision to discharge from ED to community already made;
•4. Decision to give SPRIX, opioid, OR SPRIX + opioid rescue already made;
•5. Treating clinician deems patient appropriate for continued analgesic management as an outpatient for the next 3-5 days;
•6. Patient has ready touch-tone (mobile or land line) telephone access, provides number (and back-up number, if possible) and agrees (verbal or written consent as mandated by site) to answer and comply with brief IVR questionnaires daily for next 4 days.

Exclusion Criteria

•Eligible subjects will meet none of the following criteria:
•1. Patient admitted or placed on observation status from ED;
•2. Patient unwilling or unable to comply with telephonic follow-up;
•3. Fracture that requires surgical repair (even if at a later date);
•4. Patient has diagnosis of any chronic pain syndrome;
•5. Patient already routinely takes NSAID or opioid agent;
•6. Treating clinician has reasonable suspicion of drug-seeking behavior or noncompliance;
•7. Nasal abnormality or illness that could affect the absorption of intranasal medication (such as: nasal discharge, rhinitis, acute upper respiratory infection, acute epistaxis, nasal polyp, nasal tumor).

Related studies

MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)

NCT07244211 · Femoral Neck Fractures

Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System

NCT07665424 · Osteoporosis, Osteoporotic Vertebral Compression Fractures

Mobility and Activity of Daily Living Outcomes After a Hip Fracture.

NCT07556263 · Hip Fractures (ICD-10 72.01-72.2)

Standardized Study Protocol of Percutaneous Vertebroplasty Based on Pedicle Nine-Grid Zoning Method

NCT07616583 · Osteoporotic Vertebral Compression Fractures, Vertebroplasty

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

NCT07027306 · Osteoporotic Fractures, Osteoporosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 12, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment843

Start dateJul 2012

Last updatedMar 12, 2014

Condition

Soft Tissue Injuries Gouty Arthritis Fractures Ureteral Colic Dysmenorrhea

Locations shown

University of Alabama at Birmingham

Birmingham, Alabama

LSU Medical Center

New Orleans, Louisiana

University of Mississippi Medical Center

Jackson, Mississippi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions